Simulations Plus, Inc. (SLP): Price and Financial Metrics

Simulations Plus, Inc. (SLP): $62.25

-3.89 (-5.88%)

POWR Rating

Component Grades













SLP Stock Summary

  • With a one year PEG ratio of 7,444.13, Simulations Plus Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 99.56% of US stocks.
  • The price/operating cash flow metric for Simulations Plus Inc is higher than 94.57% of stocks in our set with a positive cash flow.
  • The ratio of debt to operating expenses for Simulations Plus Inc is higher than it is for about merely 6.91% of US stocks.
  • If you're looking for stocks that are quantitatively similar to Simulations Plus Inc, a group of peers worth examining would be IIN, SSTK, TRUE, OSIS, and ICUI.
  • Visit SLP's SEC page to see the company's official filings. To visit the company's web site, go to

SLP Stock Price Chart Interactive Chart >

Price chart for SLP

SLP Price/Volume Stats

Current price $62.25 52-week high $90.92
Prev. close $66.14 52-week low $26.00
Day low $61.60 Volume 274,436
Day high $65.94 Avg. volume 217,429
50-day MA $76.23 Dividend yield 0.36%
200-day MA $65.48 Market Cap 1.24B

Simulations Plus, Inc. (SLP) Company Bio

Simulations Plus develops and produces software for use in pharmaceutical research and for education, and provides consulting and contract research services to the pharmaceutical industry. The company was founded in 1996 and is based in Lancaster, California.

SLP Latest News Stream

Event/Time News Detail
Loading, please wait...

SLP Latest Social Stream

Loading social stream, please wait...

View Full SLP Social Stream

Latest SLP News From Around the Web

Below are the latest news stories about Simulations Plus Inc that investors may wish to consider to help them evaluate SLP as an investment opportunity.

Simulations Plus and the University of Pittsburgh Drug Discovery Institute Receive SBIR Grant Funding for Large Molecule Safety Collaboration

Simulations Plus announced that its DILIsym division and the University of Pittsburgh Drug Discovery Institute jointly received a Phase I SBIR grant.

Yahoo | February 23, 2021

What We Learned About Simulations Plus' (NASDAQ:SLP) CEO Pay

Shawn O'Connor became the CEO of Simulations Plus, Inc. ( NASDAQ:SLP ) in 2018, and we think it's a good time to look...

Yahoo | February 22, 2021

Simulations Plus (SLP) Presents At MedTech, Digital Health, Life Science & Diagnostic Tools Virtual Conference - Slideshow

The following slide deck was published by Simulations Plus, Inc. in conjunction with this event....

SA Transcripts on Seeking Alpha | February 20, 2021

Simulations Plus to Participate in BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference

Simulations Plus will host fireside chat at BTIG's Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on Feb. 18, at 12pm ET.

Yahoo | February 11, 2021

Simulations Plus: Niche Market Leader With Strong Balance Sheet

Simulations Plus, Inc. (NASDAQ: SLP) is a niche market leader with high-margin software and services (consulting) businesses in modelling and simulation for drug discovery and development. It has demonstrated a strong track record of execution via organic growth and accretive acquisition. This model has enabled it to generate free cash...

Libertus Research on Seeking Alpha | February 6, 2021

Read More 'SLP' Stories Here

SLP Price Returns

1-mo -23.12%
3-mo 8.24%
6-mo 3.98%
1-year 81.42%
3-year 296.95%
5-year 634.26%
YTD -13.37%
2020 148.64%
2019 47.45%
2018 25.26%
2017 69.51%
2016 -0.44%

SLP Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full SLP Dividend History

Continue Researching SLP

Here are a few links from around the web to help you further your research on Simulations Plus Inc's stock as an investment opportunity:

Simulations Plus Inc (SLP) Stock Price | Nasdaq
Simulations Plus Inc (SLP) Stock Quote, History and News - Yahoo Finance
Simulations Plus Inc (SLP) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 2.0331 seconds.